Latest Crop Protection News

Nufarm is pairing a narrower crop-protection portfolio with heavier investment in seeds and tighter capital controls as it targets A$370 million to A$380 million in FY26 underlying EBITDA. The company has reaffirmed positive free cash flow, leverage of about 2.0 times and a A$50 million cost-saving program due to reach run-rate by the end of FY27.

Nufarm expects FY26 underlying EBITDA to rise about 25% at the midpoint of its $370 million to $380 million range, while leverage falls from 2.7 times to approximately 2.0 times. The improvement comes alongside a sweeping cost-reduction program, but restructuring charges of up to $110 million post tax remain in the numbers.

DGL Group's FY26 results show a $5.8 million underlying loss amid investments in manufacturing and logistics capacity, with the company targeting margin improvements through better utilisation and cost control in FY27.

Nufarm Limited posted a 35% rise in underlying net profit after tax to $52.1 million for HY26, driven by margin expansion and cost discipline despite a 5% revenue decline to $1.71 billion. The company confirmed its FY26 outlook, targeting strong earnings growth and leverage reduction.

Bio-Gene Technology has raised A$3.21 million to complete critical safety studies for its novel insecticide Flavocide and ramp up production of its natural insecticide Qcide, advancing its path to commercialisation in multiple global markets.

DGL Group reported a 5.8% revenue decline to $225.2 million in H1 FY26, weighed down by audit qualifications, ERP rollout delays, and one-off impairments. Despite these headwinds, the company cut net debt by $16.4 million and advanced strategic site consolidations and new facility investments.

Nufarm reports a robust first half of FY26 with underlying EBITDA rising 17% and net debt falling by $130 million, while new CEO Rico Christensen initiates a $50 million cost savings program as part of a strategic refresh.

Nufarm posted a 17% rise in underlying EBITDA for 1H FY26 and unveiled a fresh $50 million cost saving initiative under new CEO Rico Christensen, aiming to sharpen earnings quality and accelerate debt reduction.

Elders Limited delivered a resilient FY25 performance with 12% EBIT growth and a strategic focus on diversification and leverage reduction. The company’s Fourth Eight Point Plan drives operational optimisation and expansion across agribusiness divisions.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Skin Elements Limited has completed a $2.5 million placement to fund the commercial rollout of its ECO Nurture bio-stimulant, targeting sustainable kiwifruit orchard protection in New Zealand.

DGL Group reported a modest revenue increase in FY25 but faced a sharp decline in profitability, compounded by an auditor’s disclaimer and ERP rollout delays impacting FY26 start.